Medicus Pharma Ltd (MDCX) vs Sanofi (SNY)
Medicus Pharma Ltd and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $97.4B against $10.0M — 9714.9× the size. Medicus Pharma Ltd has negative trailing earnings, so its P/E is not meaningful; Sanofi trades at 21.5×. Sanofi has the higher net margin (8.22% vs 0.00%) and the higher return on invested capital (6.58% vs −2,497.5%). Across the 12 metrics below, Sanofi leads on 9 and Medicus Pharma Ltd on 3.
Valuation
Profitability
| Metric | MDCX | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | — | 72.78% | 72.77% |
| Operating margin | 0.00% | 18.24% | 18.90% |
| Net margin | 0.00% | 8.22% | 8.27% |
| Free cash flow margin | 0.00% | 25.53% | 17.25% |
| Return on equity | (7,441.07%) | 5.87% | 6.97% |
| Return on assets | (290.34%) | 3.21% | 2.76% |
| Return on invested capital | (2,497.51%) | 6.58% | 6.30% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack